Prostate Cancer Drugs

Why This Topic Matters

The article matters because it addresses a common reimbursement and compliance question in urology: whether multiple suspicious bladder sites can be billed separately or only once. It highlights the tension between payer payment behavior, professional guidance, and practice-level billing risk.

Article Sections

1. Billing Multiple Bladder Biopsies in Bladder Mapping

   Discusses coding considerations for bladder mapping in a previously diagnosed bladder cancer patient and the general issue of reporting multiple suspicious biopsy sites.

2. Professional Guidance and Payer Response

   Summarizes references to specialty guidance and the practical impact of payer adjudication on billing decisions in urology.

3. Differing Coding Perspectives

   Presents contrasting viewpoints from coders and urology practices on how specimen submission and lesion location affect billing approaches.